NASDAQ:CCXI
Delisted
ChemoCentryx Stock News
$51.99
+0 (+0%)
At Close: Jan 27, 2023
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs May 1.)
Arcturus Therapeutics Ltd (...
Traders Purchase High Volume of Call Options on ChemoCentryx (NASDAQ:CCXI)
10:24am, Thursday, 30'th Apr 2020
ChemoCentryx Inc (NASDAQ:CCXI) was the target of unusually large options trading activity on Wednesday. Investors acquired 3,724 call options on the company. This is an increase of approximately 571%
Emerald Mutual Fund Advisers Trust Buys BellRing Brands Inc, Blueprint Medicines Corp, Science ...
12:00am, Thursday, 30'th Apr 2020Analysts Estimate ChemoCentryx (CCXI) to Report a Decline in Earnings: What to Look Out for
04:31pm, Monday, 27'th Apr 2020
ChemoCentryx (CCXI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate ChemoCentryx (CCXI) to Report a Decline in Earnings: What to Look Out for
04:31pm, Monday, 27'th Apr 2020
ChemoCentryx (CCXI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate ChemoCentryx (CCXI) to Report a Decline in Earnings: What to Look Out for
12:00am, Monday, 27'th Apr 2020ChemoCentryx Inc (NASDAQ:CCXI) Expected to Announce Quarterly Sales of $8.90 Million
07:28am, Sunday, 26'th Apr 2020
Equities research analysts expect ChemoCentryx Inc (NASDAQ:CCXI) to post sales of $8.90 million for the current quarter, Zacks reports. Five analysts have made estimates for ChemoCentryx’s earnings,
Zacks Investment Research Upgrades ChemoCentryx (NASDAQ:CCXI) to "Buy"
07:48am, Saturday, 25'th Apr 2020
Zacks Investment Research upgraded shares of ChemoCentryx (NASDAQ:CCXI) from a hold rating to a buy rating in a report issued on Tuesday, Zacks.com reports. Zacks Investment Research currently has $58
Biotech Melt-Up
01:00pm, Thursday, 23'rd Apr 2020
A high daily death toll suggests a much more careful and measured reopening of the economy will be possible, not a quick-paced one. The pandemic thrusts the bio
Here's Why Momentum Investors Will Love ChemoCentryx (CCXI)
04:00pm, Wednesday, 22'nd Apr 2020
Does ChemoCentryx (CCXI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Here's Why Momentum Investors Will Love ChemoCentryx (CCXI)
04:00pm, Wednesday, 22'nd Apr 2020
Does ChemoCentryx (CCXI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Bank of America Corp DE Sells 40,615 Shares of ChemoCentryx Inc (NASDAQ:CCXI)
09:50am, Wednesday, 22'nd Apr 2020
Bank of America Corp DE reduced its position in shares of ChemoCentryx Inc (NASDAQ:CCXI) by 51.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange
The Daily Biotech Pulse: Applied DNA Begins Validating COVID-19 Test, Cara's Positive Readout, Novan Explores Strategic Alternatives
12:19pm, Tuesday, 21'st Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 20) * Abbott Laboratories (NYSE: ABT) * Acceleron Phar
The Daily Biotech Pulse: Applied DNA Begins Validating COVID-19 Test, Cara's Positive Readout, Novan Explores Strategic Alternatives
12:00am, Tuesday, 21'st Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs April 20)
Abbott Laboratories (NYSE...
Frontier Capital Management Co. LLC Sells 138,229 Shares of ChemoCentryx Inc (NASDAQ:CCXI)
10:14am, Monday, 20'th Apr 2020
Frontier Capital Management Co. LLC cut its position in shares of ChemoCentryx Inc (NASDAQ:CCXI) by 91.5% during the first quarter, according to the company in its most recent disclosure with the Secu
